Anika Therapeutics, Inc. (ANIK) Reports Q2 Earnings of $0.17, Revenues Increase Y/Y
Anika Therapeutics, Inc. (NASDAQ: ANIK) reported Q2 EPS of $0.17, versus $0.08 reported last year. Revenue for the quarter came in at $16.1 million, versus $13.7 million reported last year.